Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial
NVX-CoV2373冠状病毒病2019疫苗在随机对照试验安慰剂对照阶段完成后的安全性和有效性
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac803
Heath, Paul T; Galiza, Eva P; Baxter, David Neil; Boffito, Marta; Browne, Duncan; Burns, Fiona; Chadwick, David R; Clark, Rebecca; Cosgrove, Catherine A; Galloway, James; Goodman, Anna L; Heer, Amardeep; Higham, Andrew; Iyengar, Shalini; Jeanes, Christopher; Kalra, Philip A; Kyriakidou, Christina; Bradley, Judy M; Munthali, Chigomezgo; Minassian, Angela M; McGill, Fiona; Moore, Patrick; Munsoor, Imrozia; Nicholls, Helen; Osanlou, Orod; Packham, Jonathan; Pretswell, Carol H; San Francisco Ramos, Alberto; Saralaya, Dinesh; Sheridan, Ray P; Smith, Richard; Soiza, Roy L; Swift, Pauline A; Thomson, Emma C; Turner, Jeremy; Viljoen, Marianne Elizabeth; Fries, Louis; Cho, Iksung; McKnight, Irene; Glenn, Greg; Rivers, E Joy; Robertson, Andreana; Alves, Katia; Smith, Kathy; Toback, Seth
